1. Rossman D, Michel R, Codere F. A case of an enlarged medial rectus muscle. Int Ophthalmol. 2009; 29:319–321.
2. Byard SD, Chowdhury HR, Lee RM, Hyer J, Hart-George AL. Unilateral isolated extraocular muscle lymphoma. BMJ Case Rep. 2012; 2012:pii: bcr0220125750.
3. Benetatos L, Alymara V, Asproudis I, Bourantas KL. Rituximab as first line treatment for MALT lymphoma of extraocular muscles. Ann Hematol. 2006; 85:625–626.
4. Abalo-Lojo JM, Baleato-Gonzalez S, Abdulkader I, Gonzalez F. Extraocular muscle involvement in MALT lymphomas. Orbit. 2011; 30:186–188.
5. Izambart C, Robert PY, Petellat F, Petit B, Gastaud P, Lagier J, et al. Extraocular muscle involvement in marginal zone B-cell lymphomas of the orbit. Orbit. 2008; 27:345–349.
6. Lacey B, Chang W, Rootman J. Nonthyroid causes of extraocular muscle disease. Surv Ophthalmol. 1999; 44:187–213.
7. Raderer M, Streubel B, Woehrer S, Puespoek A, Jaeger U, Formanek M, et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res. 2005; 11:3349–3352.
8. Lee JL, Kim MK, Lee KH, Hyun MS, Chung HS, Kim DS, et al. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa. Ann Hematol. 2005; 84:13–18.
9. Zhao K, Luo YZ, Zhou SH, Dai BL, Luo XM, Yan SX, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in mucosa-associated lymphoid tissue lymphoma of the larynx: a case report and literature review. J Int Med Res. 2012; 40:1192–1206.
10. Pfeffer MR, Rabin T, Tsvang L, Goffman J, Rosen N, Symon Z. Orbital lymphoma: is it necessary to treat the entire orbit? Int J Radiat Oncol Biol Phys. 2004; 60:527–530.